Cargando…

P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME

Detalles Bibliográficos
Autores principales: Grafakos, I., Papadakis, V., Antoniadi, K., Ampatzidou, M., Papargyri, S., Kelaidi, C., Tzotzola, V., Polychronopoulou, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431024/
http://dx.doi.org/10.1097/01.HS9.0000849080.56756.8d
_version_ 1784779939635003392
author Grafakos, I.
Papadakis, V.
Antoniadi, K.
Ampatzidou, M.
Papargyri, S.
Kelaidi, C.
Tzotzola, V.
Polychronopoulou, S.
author_facet Grafakos, I.
Papadakis, V.
Antoniadi, K.
Ampatzidou, M.
Papargyri, S.
Kelaidi, C.
Tzotzola, V.
Polychronopoulou, S.
author_sort Grafakos, I.
collection PubMed
description
format Online
Article
Text
id pubmed-9431024
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94310242022-08-31 P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME Grafakos, I. Papadakis, V. Antoniadi, K. Ampatzidou, M. Papargyri, S. Kelaidi, C. Tzotzola, V. Polychronopoulou, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431024/ http://dx.doi.org/10.1097/01.HS9.0000849080.56756.8d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Grafakos, I.
Papadakis, V.
Antoniadi, K.
Ampatzidou, M.
Papargyri, S.
Kelaidi, C.
Tzotzola, V.
Polychronopoulou, S.
P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
title P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
title_full P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
title_fullStr P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
title_full_unstemmed P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
title_short P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
title_sort p1556: hyper -ferritinemia in pediatric oncology patients secondary to treatment: diagnostic approach and outcome
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431024/
http://dx.doi.org/10.1097/01.HS9.0000849080.56756.8d
work_keys_str_mv AT grafakosi p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT papadakisv p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT antoniadik p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT ampatzidoum p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT papargyris p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT kelaidic p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT tzotzolav p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome
AT polychronopoulous p1556hyperferritinemiainpediatriconcologypatientssecondarytotreatmentdiagnosticapproachandoutcome